Racial Disparities in Treatment and Survival Among Women With Early-Stage Breast Cancer Twenty-three assessable patients taking EIAEDs received tipifarnib in escalating doses from 300 to 700 mg bid ...

A drug effective in treating breast cancer shows new promise in addressing breast cancer with brain metastases or recurrent glioblastoma, as reported by results of a prospective window-of-opportunity ...

Please provide your email address to receive an email when new articles are posted on . Patients with drug reactions with eosinophilia and systemic symptoms show increases in Th2-associated cytokines.

Urticaria, the second most common drug eruption after exanthematous drug eruptions, 1 is characterized by episodic short-lived swellings of the skin, oropharnyx, or genitalia. Transient leakage of ...

The anti-cancer drug olaparib may be effective in treating biochemically recurrent prostate cancer without accompanying hormone therapy for men who have mutations in genes such as BRCA2, according to ...

Nearly half of the adolescents and adults who developed rashes from penicillin during an Epstein-Barr virus (EBV) infection showed evidence of persistent drug hypersensitivity. Patients with EBV ...

BARCELONA, Spain — A single pill that incorporates low doses of three different antihypertensives reduced recurrent stroke by approximately 40% in patients with a history of intracerebral hemorrhage ...

BOSTON--(BUSINESS WIRE)--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced that the U.S. Food and Drug ...

Mustang Bio, Inc. announced that its IL13Ra2-targeted CAR T-cell therapy, MB-101, received Orphan Drug Designation from the FDA for treating recurrent diffuse and anaplastic astrocytomas and ...